Search research articles
Contact Us
Filters
Showing results (21-30 of 33) with videos related to
Page
of 4
Sort By:
European Journal of Nuclear Medicine
|
June 15, 2000
Iterative reconstruction: an improvement of technetium-99m MIBI SPET for the detection of parathyroid adenomas?
D Moka, W Eschner, E Voth, et al.
Nuklearmedizin. Nuclear Medicine
|
June 13, 2003
[Procedure guideline for radioiodine test (version 2)]
M Dietlein, J Dressler, W Eschner, et al.
Nuklearmedizin. Nuclear Medicine
|
February 19, 2008
Graves' disease and radioiodine therapy. Is success of ablation dependent on the achieved dose above 200 Gy?
C Kobe, W Eschner, F Sudbrock, et al.
Nuklearmedizin. Nuclear Medicine
|
October 17, 2007
[Procedure guideline for radioiodine test (Version 3)]
M Dietlein, J Dressler, W Eschner, et al.
Nuklearmedizin. Nuclear Medicine
|
August 12, 2008
Graves' disease and radioiodine therapy. Is success of ablation dependent on the choice of thyreostatic medication?
C Kobe, I Weber, W Eschner, et al.
Nuclear Medicine Communications
|
February 24, 2001
Follow-up of differentiated thyroid cancer: comparison of multiple diagnostic tests
M Dietlein, D Moka, K Scheidhauer, et al.
Nuklearmedizin. Nuclear Medicine
|
September 12, 2006
Is there a benefit of 131 I-MIBG therapy in the treatment of children with stage 4 neuroblastoma? A retrospective evaluation of The German Neuroblastoma Trial NB97 and implications for The German Neuroblastoma Trial NB2004
M Schmidt, T Simon, B Hero, et al.
Nuklearmedizin. Nuclear Medicine
|
June 18, 2004
18F-FDG PET for detecting recurrent head and neck cancer, local lymph node involvement and distant metastases. Comparison of qualitative visual and semiquantitative analysis
M Schmidt, M Schmalenbach, M Jungehülsing, et al.
Nuklearmedizin. Nuclear Medicine
|
September 16, 2005
[Radioimmunotherapy with yttrium-90 ibritumomab tiuxetan. Clinical considerations, radiopharmacy, radiation protection, perspectives]
K Schomäcker, M Dietlein, R Schnell, et al.
Nuklearmedizin. Nuclear Medicine
|
October 17, 2007
[Procedure guideline for iodine-131 whole-body scintigraphy for differentiated thyroid cancer (version 3)]
M Dietlein, J Dressler, W Eschner, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 33) with videos related to
Sort By:
Page
of 4
European Journal of Nuclear Medicine
|
June 15, 2000
Iterative reconstruction: an improvement of technetium-99m MIBI SPET for the detection of parathyroid adenomas?
D Moka, W Eschner, E Voth, et al.
Nuklearmedizin. Nuclear Medicine
|
June 13, 2003
[Procedure guideline for radioiodine test (version 2)]
M Dietlein, J Dressler, W Eschner, et al.
Nuklearmedizin. Nuclear Medicine
|
February 19, 2008
Graves' disease and radioiodine therapy. Is success of ablation dependent on the achieved dose above 200 Gy?
C Kobe, W Eschner, F Sudbrock, et al.
Nuklearmedizin. Nuclear Medicine
|
October 17, 2007
[Procedure guideline for radioiodine test (Version 3)]
M Dietlein, J Dressler, W Eschner, et al.
Nuklearmedizin. Nuclear Medicine
|
August 12, 2008
Graves' disease and radioiodine therapy. Is success of ablation dependent on the choice of thyreostatic medication?
C Kobe, I Weber, W Eschner, et al.
Nuclear Medicine Communications
|
February 24, 2001
Follow-up of differentiated thyroid cancer: comparison of multiple diagnostic tests
M Dietlein, D Moka, K Scheidhauer, et al.
Nuklearmedizin. Nuclear Medicine
|
September 12, 2006
Is there a benefit of 131 I-MIBG therapy in the treatment of children with stage 4 neuroblastoma? A retrospective evaluation of The German Neuroblastoma Trial NB97 and implications for The German Neuroblastoma Trial NB2004
M Schmidt, T Simon, B Hero, et al.
Nuklearmedizin. Nuclear Medicine
|
June 18, 2004
18F-FDG PET for detecting recurrent head and neck cancer, local lymph node involvement and distant metastases. Comparison of qualitative visual and semiquantitative analysis
M Schmidt, M Schmalenbach, M Jungehülsing, et al.
Nuklearmedizin. Nuclear Medicine
|
September 16, 2005
[Radioimmunotherapy with yttrium-90 ibritumomab tiuxetan. Clinical considerations, radiopharmacy, radiation protection, perspectives]
K Schomäcker, M Dietlein, R Schnell, et al.
Nuklearmedizin. Nuclear Medicine
|
October 17, 2007
[Procedure guideline for iodine-131 whole-body scintigraphy for differentiated thyroid cancer (version 3)]
M Dietlein, J Dressler, W Eschner, et al.
Page
of 4